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Gaining invasiveness and overcoming the physical barriers imposed by the extracellular matrix (ECM) are the first, and arguably most critical, steps of tumor metastasis. 1 In addition to facilitating dissemination, remodeling of the ECM is essential for tumor growth and the establishment of metastatic niches by malignant cells. 2 Invadopodia of malignant cancer cells are actin-rich, ECM-degrading membrane protrusions that are critical for tumor invasion and metastasis. 1 In a recent study, we investigated the regulation of invadopodium formation and metastasis by Ca 2C signaling in melanoma. 3 We unexpectedly discovered that hyperactive Ca 2C signaling in metastatic melanoma cells is organized in the form of oscillatory waves to orchestrate invadopodia assembly and melanoma invasion. 3 In recent years, dysregulated Ca 2C signaling has been increasingly implicated in cancer invasion and metastasis, yet the underlying mechanism remained largely unclear. 4, 5 The specificity and versatility of Ca 2C signaling relies on the intricate spatial and temporal coding of cytosolic Ca 2C concentration. 6 By compartmentalizing Ca 2C signals into spatial-temporal patterns, cells are able to activate selective downstream signaling events at a defined time and subcellular location. 6 It is believed that the frequency and amplitude of Ca 2C oscillations serve as digital signals that selectively activate threshold-dependent downstream events. The tight control of cytosolic Ca 2C is critical not only for signaling specificity but also for cell survival, since a prolonged and uncontrolled global increase in cytosolic Ca 2C is toxic to the cell and eventually leads to cell death. 7 By organizing SOCE signals in the form of Ca 2C oscillation, melanoma cells are able to provide the Ca 2C signal necessary for invadopodium assembly and ECM remodeling over an extended period of time without causing cytotoxicity (Fig. 1A) . In contrast, although constitutive Ca 2C influx induced by thapsigargin and A23187 robustly increases Src activity it might also indiscriminately activate hundreds of other Ca 2C -dependent signaling pathways, which eventually reduce melanoma cell fitness and inhibit melanoma invasion (Fig. 1B) .
It is also possible that melanoma invasion and invadopodium assembly require a coordinated cycle of Ca 2C peaks and valleys, as recently demonstrated in mast cell exocytosis by Wollman and Meyer. 8 Ca
2C
oscillation in antigen-activated mast cells drives the cyclic assembly and disassembly of cortical actin. Newly assembled cortex actin serves as a carrier to capture secretory vesicles, whereas disassembly of cortical actin allows the passage of vesicles to facilitate membrane fusion. Intriguingly, we discovered that recycling of membrane type 1 matrix metalloprotease (MT1-MMP, also known as MMP14) to the plasma membrane required SOCE, blockage of which resulted in entrapment of MT1-MMP in endosomes. 3 It would be interesting to determine whether SOCEmediated Ca 2C oscillation coordinates the recycling of endocytosed MT1-MMP to the plasma membrane.
Of note, tumor-promoting Ca 2C oscillation has also recently been observed in esophageal squamous cell carcinoma and hepatocellular carcinoma (HCC). 9, 10 Overexpression of Orai1 in esophageal carcinoma cells is responsible for hyperactive Ca 2C oscillation, which promotes cancer cell motility and proliferation in vitro and tumor growth in a xenograft model. 10 In HCC the voltage-gated calcium channel subunit CACNA2D1 was found to be a marker for recurrent disease.
Recurrent HCC cells had higher expression of a2d1 and hyperactive Ca 2C oscillation, which could be inhibited by a blocking antibody targeting CAC-NA2D1. 10 These observations, together with our recent finding, suggest that Ca 2C oscillation might be a signaling mechanism that is commonly hijacked by malignant cells to facilitate cancer progression. Future investigation in this area will likely significantly advance our understanding of how deregulated Ca 2C signaling promotes cancer malignancy.
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